4.6 Article

Multicontrast nonlinear optical microscopy with a compact and rapid pulse shaper

Journal

OPTICS LETTERS
Volume 37, Issue 13, Pages 2763-2765

Publisher

OPTICAL SOC AMER
DOI: 10.1364/OL.37.002763

Keywords

-

Categories

Ask authors/readers for more resources

Homodyne detection can dramatically enhance measurement sensitivity for weak signals. In nonlinear optical microscopy it can make accessible a range of novel, intrinsic, contrast like nonlinear absorption and nonlinear phase contrast. Here a compact and rapid pulse shaper is developed, implemented, and demonstrated for homodyne detection in nonlinear microscopy with high-repetition rate mode-locked femtosecond lasers. With this method we generate two-photon absorption (TPA) and self-phase modulation images of gold nanostars in biological samples. Simultaneous imaging of two-photon luminescence and TPA also enables us to produce two-photon quantum yield images. (C) 2012 Optical Society of America

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Optics

Beyond intensity modulation: new approaches to pump-probe microscopy

Jun Jiang, David Grass, Yue Zhou, Warren S. Warren, Martin C. Fischer

Summary: Pump-probe microscopy is an emerging nonlinear imaging technique that uses high repetition rate lasers and fast intensity modulation. New methods for pump-probe microscopy have been developed that keep the beam intensity constant by modulating either the inter-pulse time delay or the relative polarization, improving image quality for samples with poor heat dissipation or long-lived radiative states. These techniques can selectively address nonlinear interactions in samples and offer advantages over conventional intensity modulation.

OPTICS LETTERS (2021)

Article Clinical Neurology

Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine

Cristina Tassorelli, Hans-Christoph Diener, Stephen D. Silberstein, David W. Dodick, Peter J. Goadsby, Rigmor H. Jensen, Delphine Magis, Patricia Pozo-Rosich, Hsiangkuo Yuan, Daniele Martinelli, Thomas van den Hoek, Marie Deen, Messoud Ashina, Gisela M. Terwindt

Summary: The International Headache Society's Clinical Trials Committee has provided recommendations for optimizing the design and conduct of controlled trials of neuromodulation devices for the acute and/or preventive treatment of migraine. This includes defining key terms, providing recommendations for assessment in different age groups, outlining ethical and administrative responsibilities, and creating a bibliography of previous research in this area. Adopting these recommendations will improve the quality of evidence regarding the use of neuromodulation devices in migraine treatment.

CEPHALALGIA (2021)

Article Chemistry, Inorganic & Nuclear

Structural, Optical, and Electronic Properties of Two Quaternary Chalcogenide Semiconductors: Ag2SrSiS4 and Ag2SrGeS4

Garrett C. McKeown Wessler, Tianlin Wang, Jon-Paul Sun, Yuheng Liao, Martin C. Fischer, Volker Blum, David B. Mitzi

Summary: Materials with quaternary chalcogenides have shown diversity and promise, with particular interest in the I-2-II-IV-X-4 family. Compounds containing both Ag and Sr have not been experimentally studied, but this research has synthesized and studied Ag2SrSiS4 and Ag2SrGeS4, with additional impurity phases identified. These materials exhibit indirect band gaps, with second-harmonic generation capabilities in the near-infrared range.

INORGANIC CHEMISTRY (2021)

Review Clinical Neurology

Update of Neuromodulation in Chronic Migraine

Hsiangkuo Yuan, Tzu-Ying Chuang

Summary: Neuromodulation devices have become an attractive alternative to traditional pharmacotherapy for migraine, especially for patients intolerant to medication or who prefer non-pharmacological options. Studies on the efficacy of these devices in chronic migraine are limited, but show promising results, although more well-designed research is needed for FDA clearance and insurance coverage.

CURRENT PAIN AND HEADACHE REPORTS (2021)

Article Clinical Neurology

Intravenous ibuprofen for acute treatment of migraine: A double-blind, randomized, placebo-controlled pilot study

Hsiangkuo Yuan, John G. Curran, Scott W. Keith, Mary M. Hopkins, Stephen D. Silberstein

Summary: The study evaluated the efficacy and safety of IV ibuprofen for acute migraine treatment. While the primary endpoint was not met, there was significant pain relief within 2 hours post-treatment with IV ibuprofen compared to placebo. Adverse events were minimal, suggesting that IV ibuprofen may be a safe and effective option for acute migraine treatment. Further studies with larger sample sizes are needed for confirmation.

HEADACHE (2021)

Review Clinical Neurology

Care Gaps and Recommendations in Vestibular Migraine: An Expert Panel Summit

Monica P. Mallampalli, Habib G. Rizk, Amir Kheradmand, Shin C. Beh, Mehdi Abouzari, Alaina M. Bassett, James Buskirk, Claire E. J. Ceriani, Matthew G. Crowson, Hamid Djalilian, Joel A. Goebel, Jeffery J. Kuhn, Anne E. Luebke, Marco Mandala, Magdalena Nowaczewska, Nicole Spare, Roberto Teggi, Maurizio Versino, Hsiangkuo Yuan, Ashley Zaleski-King, Michael Teixido, Frederick Godley

Summary: Vestibular migraine is increasingly recognized as a pathological cause of vestibular disorders, yet it remains underdiagnosed. The pathophysiology of this disorder is still unclear. A multidisciplinary expert workshop identified seven current care gaps that need to be resolved, including a better understanding of symptoms and phenotypes, a lack of diagnostic markers, a better understanding of pathophysiological mechanisms, as well as the need for clear recommendations and outcome measures. Recommendations were made to address these gaps, such as establishing a global registry and conducting trials to validate current treatments.

FRONTIERS IN NEUROLOGY (2022)

Review Oncology

Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale

Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein

Summary: Calcitonin gene-related peptide (CGRP) is believed to be involved in the pathogenesis of migraine, and there are two classes of therapeutic agents targeting CGRP: CGRP-targeted monoclonal antibodies and small-molecule antagonists. Multiple clinical studies have shown the efficacy and tolerability of these treatments.

BIODRUGS (2022)

Article Clinical Neurology

Most bothersome symptoms in patients with migraine: A hospital-based study in Taiwan

Yi-Hsien Tu, Yen-Feng Wang, Hsiangkuo Yuan, Shih-Pin Chen, Yi-Shiang Tzeng, Wei-Ta Chen, Kuan-Lin Lai, Yu-Hsiang Ling, Shuu-Jiun Wang

Summary: This study investigated the distribution, clinical associations, and treatment responses for the most bothersome symptoms of migraine in a large sample of patients in Taiwan. Nausea was found to be the most common most bothersome symptom, followed by phonophobia and photophobia. The response rates to previous acute treatments for different most bothersome symptoms were similar.

HEADACHE (2022)

Review Clinical Neurology

The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine

Fred Cohen, Hsiangkuo Yuan, E. M. G. DePoy, Stephen D. Silberstein

Summary: Remarkable advancements have been made in the field of migraine research and treatment, particularly with the discovery of CGRP functional blocking monoclonal antibodies (mAbs) as an effective preventive therapy for both chronic and episodic migraine. These mAbs offer advantages such as high affinity and selectivity, long-circulating plasma half-lives, and limited risk for side effects and drug-drug interactions. However, long-term safety and use during pregnancy should be further studied.

NEUROTHERAPEUTICS (2022)

Review Health Care Sciences & Services

Role of Atogepant in the Treatment of Episodic Migraines: Clinical Perspectives and Considerations

Fred Cohen, Hsiangkuo Yuan

Summary: Advances in molecular biology and neuroscience have led to the discovery of CGRP and its role in migraine. Gepants, including atogepant, are oral medications that inhibit CGRP receptors to prevent migraine attacks and neurogenic inflammation.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2022)

Article Optics

Contrast mechanisms in pump-probe microscopy of melanin

David Grass, Georgia M. Beasley, Martin C. Fischer, M. Angelica Selim, Yue Zhou, Warren S. Warren

Summary: Pump-probe microscopy is proposed to improve the diagnosis of malignant melanoma by analyzing the signals of melanin. The study decomposes the signals and identifies the molecular mechanisms most susceptible to melanin disaggregation, creating false-colored images to highlight these processes in biological tissue. The results demonstrate a correlation between false-colored images of melanoma tumors and clinical concern, and the approach can be applied to other samples.

OPTICS EXPRESS (2022)

Review Clinical Neurology

Short-lasting unilateral neuralgiform headache attacks (SUNCT/SUNA): a narrative review of interventional therapies

Rupert D. Smit, Nikolaos Mouchtouris, KiChang Kang, Maikerly Reyes, Anish Sathe, Sarah Collopy, Giyarpuram Prashant, Hsiangkuo Yuan, James J. Evans

Summary: This literature review examines the evidence for interventional therapies in medically intractable SUNCT/SUNA, including occipital nerve stimulation, pulsed radiofrequency, stereotactic radiosurgery, and microvascular decompression. The review finds promising outcomes with these treatments, but emphasizes the need for further research.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2023)

Article Anesthesiology

Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis

Hsiangkuo Yuan, Aniket Natekar, Jade Park, Clinton G. Lauritsen, Eugene R. Viscusi, Michael J. Marmura

Summary: This retrospective study assessed the prevalence, harms, and effectiveness of prescription drug misuse and "lean" (cough syrup) in patients with treatment-resistant headaches. The results showed that both prescription drug misuse and "lean" were common among patients with treatment-resistant headaches, but they were not effective in treating headaches.

REGIONAL ANESTHESIA AND PAIN MEDICINE (2023)

Article Anesthesiology

Debunking myths in headache diagnosis for the pain practitioner

Hsiangkuo Yuan, Samantha Strutner, Clara Yuh, Suwarna Anand, Gaurav Chauhan, Anand Prem, Shalini Shah, Nathaniel M. Schuster

Summary: With headache being a common complaint, accurately diagnosing and treating specific headache disorders requires understanding and differentiating various headache characteristics. This article discusses several myths about common headache disorders and provides a discussion based on the International Classification of Headache Disorders and the latest studies. Understanding the intricacies of headache diagnoses helps providers provide better care for patients.

REGIONAL ANESTHESIA AND PAIN MEDICINE (2023)

No Data Available